QA: Dynavax Technologies CORP in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2015_Dynavax_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001029142, Dynavax Technologies CORP

  xvar xval
0 AssetsCurrent 127,437,000
1 IntangibleAssetsNetIncludingGoodwill 2,277,000
2 PropertyPlantAndEquipmentNet 7,924,000
3 remainder_Assets 652,000
4 LiabilitiesCurrent 20,279,000
5 LiabilitiesNoncurrent 1,070,000
6 remainder_Liabilities 16,459,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,096,516
9 ResearchAndDevelopmentExpense 83,864,330
10 remainder_Expenses 357,294
11 remainder_Revenues 11,101,380
12 remainder_NetIncome 341,734
13 remainder_ComprehensiveNetIncome -1,068,934
  yvar yval
0 Assets 138,290,000
1 Liabilities 37,808,000
2 Expenses 95,318,140
3 Revenues 11,101,380
4 StockholdersEquity 100,482,000
5 NetIncome -83,875,026
6 ComprehensiveNetIncome -84,409,493
7 BaseVar 141,964,094
8 EconomicCapitalRatiobeforeLimitedLiability 1.53
9 EconomicCapitalRatio 2.70

Edgar->Model Mapping

Feature Distribution

Change over Time